Ronald Campbell Loucks

CA·SEDI

NexgenRx Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (2 ops.)

€34k

▼ Sales (0 ops.)

—

Latest filing published 27 May 2024 for NexgenRx Inc., €23k.

Filing timeline

BuySale

Ronald Campbell Loucks

Insider track record

Disclosed buys

Disclosed sells

Signal history

Ronald Campbell Loucks: trading record in brief

Ronald Campbell Loucks appears in our data through filings on NexgenRx Inc. shares, published by SEDI. We count 6 filings; the first trade dates from 28 August 2006 and the latest from 24 May 2024.

No open-market sale appears; the market trades are 2 purchases worth €34k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 option exercise. 2024 to date brings 1 purchase and no sales.

Most recently, on 27 May 2024, the filings show an open-market purchase worth €23k in NexgenRx Inc. Typically, a trade is published a median of 3 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.

Companies and markets linked to Ronald Campbell Loucks

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

NexgenRx Inc. (CA)

Declarations6 total

▲

Ronald Campbell Loucks

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives24 May 2024NexgenRx Inc.

33,600 CAD14SEDI

120,000 shares@ CA$0.2826.4% of flowCommon SharesTSXSEDI:4319771

Canonical exit: 22 Aug 2024 (T+90)

●

Ronald Campbell Loucks

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Jul 2020NexgenRx Inc.

200,000 CAD17SEDI

800,000 shares@ CA$0.2560.4% of flowPreferred Shares Series 1TSXSEDI:3575148

●

Ronald Campbell Loucks

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives28 Aug 2006NexgenRx Inc.

0SEDI

Preferred Shares Series 1TSXSEDI:3575144

●

Ronald Campbell Loucks

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Oct 2018NexgenRx Inc.

15,000 CAD19SEDI

60,000 shares@ CA$0.25100.0% of flowCommon SharesTSXSEDI:3251093

◇

Ronald Campbell Loucks

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives30 Dec 2016NexgenRx Inc.

60,000 CAD20SEDI

300,000 shares@ CA$0.2066.8% of flowCommon SharesTSXSEDI:2934073

▲

Ronald Campbell Loucks

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives29 Jul 2016NexgenRx Inc.

16,000 CAD13SEDI

100,000 shares@ CA$0.1617.4% of flowCommon SharesTSXSEDI:2870982

Canonical exit: 27 Oct 2016 (T+90)

6 of 6 declarations

Ronald Campbell Loucks: trading record in brief

Ronald Campbell Loucks appears in our data through filings on NexgenRx Inc. shares, published by SEDI. We count 6 filings; the first trade dates from 28 August 2006 and the latest from 24 May 2024.

Ronald Campbell Loucks

Insider track record

Ronald Campbell Loucks: trading record in brief

Companies and markets linked to Ronald Campbell Loucks

Related entities

Ronald Campbell Loucks

Insider track record

Ronald Campbell Loucks: trading record in brief

Companies and markets linked to Ronald Campbell Loucks

Related entities